Diffuse intrinsic pontine glioma, or DIPG, typically announces itself through a combination of eye movement problems, difficulty with balance and coordination, and weakness or abnormal reflexes in the limbs. These three categories of symptoms form a well-recognized pattern that develops over a strikingly short window, with most children presenting about a month after something first seems off. Because the tumor grows in the pons, a compact region of the brainstem that serves as a relay hub for movement, sensation, and cranial nerve function, the symptoms it produces map closely to the structures it disrupts.
The Classic Symptom Triad
Clinicians describe a characteristic trio of problems in children with DIPG: cranial nerve palsy (especially involving the nerve that moves the eye outward), cerebellar dysfunction affecting balance and coordination, and pyramidal tract signs like abnormal reflexes or limb weakness. Of these, cranial nerve involvement is the most common initial finding, appearing in roughly 70 to 82 percent of cases at diagnosis.1PubMed Central. Ophthalmic Presentation of Diffuse Intrinsic Pontine Glioma in Children (Case Series and Literature Review) The sixth cranial nerve, which controls outward eye movement, is usually the first to be affected, and its palsy is present in the vast majority of children by the time they receive a diagnosis.2PubMed Central. Current treatment options in neurology – Section: Diagnostic evaluation
In practice, parents often notice that their child has developed a new squint or that one eye turns inward, particularly when looking to one side. The child may begin tilting their head to compensate or complaining of double vision. These eye-related changes can be subtle at first and are sometimes mistaken for a simple need for glasses before more alarming symptoms follow.
How Fast Symptoms Develop
One of the hallmarks of DIPG is the speed at which symptoms accumulate. The median time from first noticeable symptoms to diagnosis is about one month, and many children present after just a few days of problems.3PubMed Central. Current treatment options in neurology – Section: Diagnostic evaluation In a study of children diagnosed at 36 months of age or younger, 60 percent were diagnosed within six weeks of symptom onset, while smaller groups had symptoms lasting six to twelve weeks (18 percent) or longer than six months (5 percent).4Neuro-Oncology. Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry Those who survived longer tended to have had a longer duration of symptoms before diagnosis, suggesting that faster-growing tumors both declare themselves sooner and carry a worse prognosis.
Occasionally, a prodromal phase stretching back as many as 16 months has been documented, though this is rare.5PubMed Central. Current treatment options in neurology – Section: Diagnostic evaluation In those unusual cases, early symptoms are often vague enough to elude diagnosis: intermittent headaches, mild clumsiness, or personality changes that only make sense in retrospect once the MRI reveals a pontine mass.
Eye and Facial Nerve Problems
Because the pons houses several cranial nerve nuclei, DIPG produces a range of problems beyond the sixth nerve palsy already described. Facial nerve weakness is common, causing one side of the face to droop or making it difficult for the child to close an eye, smile symmetrically, or blow out their cheeks. A clinical assessment scale developed specifically for DIPG tracks ophthalmoplegia (limited eye movement), facial weakness, and tongue weakness as distinct items, reflecting how frequently each appears.6PubMed. Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore
A case report of a 14-year-old girl with DIPG illustrates how several cranial nerve and motor problems cluster together: she presented with a right sixth nerve palsy, left-sided facial weakness, slurred speech, coordination problems in both arms, and an unsteady, wide-based walk.7Nature. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas – Section: Dose level 1 That combination, eye movement trouble on one side, facial droop on the other, plus whole-body coordination deficits, is typical of a tumor that infiltrates across the midline of the pons rather than staying neatly on one side.
The practical impact of cranial nerve dysfunction extends beyond what shows up on a neurological exam. Children may drool because they cannot control one side of the mouth, their speech can become increasingly difficult to understand, and swallowing can become unsafe as lower cranial nerves are affected. These bulbar symptoms are among the most distressing for families, because they erode the child’s ability to communicate and eat normally.
Balance, Coordination, and Limb Weakness
The pons sits right in front of the cerebellum and contains fibers that connect the two brain halves to it. DIPG commonly disrupts these connections, producing cerebellar signs such as unsteady walking, poor coordination of arm or leg movements, and slurred speech caused by difficulty coordinating the muscles used in speaking.8PubMed Central. Exceptional Tumor Regression in Diffuse Intrinsic Pontine Glioma Post-Radiotherapy: A Case Study – Section: Discussion Parents often describe their child as suddenly clumsy, tripping over things, or unable to catch a ball the way they used to.
Separately, the tumor can invade long nerve tracts running through the brainstem that connect the brain to the spinal cord, producing what clinicians call pyramidal tract signs. These include increased reflexes, stiffness in the limbs, weakness on one or both sides, and an abnormal toe reflex where the big toe curls upward instead of downward when the sole of the foot is stroked.9PubMed Central. Exceptional Tumor Regression in Diffuse Intrinsic Pontine Glioma Post-Radiotherapy: A Case Study – Section: Discussion Numbness or tingling in the limbs can also appear, though sensory symptoms tend to get less attention than the more visible motor problems.
Imaging studies have shown that when the tumor extends into the middle cerebellar peduncles, the thick fiber bundles connecting the pons to the cerebellum, it correlates with shorter survival.10American Journal of Neuroradiology. MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas This makes intuitive sense: greater disruption of pons-to-cerebellum communication means worse coordination and likely reflects more aggressive tumor biology.
Headaches and Rising Pressure Inside the Skull
Morning headaches are among the most commonly reported early symptoms of DIPG.11PubMed Central. Exceptional Tumor Regression in Diffuse Intrinsic Pontine Glioma Post-Radiotherapy: A Case Study – Section: Discussion These headaches tend to be worst upon waking because lying flat overnight increases intracranial pressure. They may improve after the child gets up and moves around, a pattern that distinguishes them from tension headaches or migraines.
As the tumor grows, it can obstruct the flow of cerebrospinal fluid through the narrow channels near the brainstem, leading to hydrocephalus, a dangerous buildup of fluid inside the brain’s ventricles. When this happens acutely, the child develops severe headache, vomiting, and sometimes impaired consciousness. In one surgical series, nine children with DIPG required an emergency procedure to relieve this fluid buildup, presenting with headache and vomiting (six patients) or reduced consciousness (three patients).12Neuro-Oncology Pediatrics. Clinical Outcomes of Endoscopic Third Ventriculostomy for Hydrocephalus of Pediatric Diffuse Intrinsic Pontine Glioma Patients Hydrocephalus does not occur in every child with DIPG, but when it does, it is a medical emergency that needs to be addressed before any cancer-directed treatment can proceed.
Behavioral and Emotional Changes That Get Overlooked
One of the more underappreciated aspects of DIPG is its effect on behavior and mood. Because the brainstem plays a role in arousal, attention, and emotional regulation, tumors in the pons can cause personality shifts that precede the neurological deficits doctors are trained to look for. A study of children with DIPG found behavioral disturbances in 14 out of a group of patients, including irritability and aggression, apathy and slowed thinking, emotional dysregulation, depressed mood, and sleep problems like nightmares or insomnia. In six of those children, behavioral changes were the very first symptom of the disease, appearing one to twelve months before any classic neurological signs.13PubMed Central. Behavioral disturbances as underestimated presenting symptoms in children with Diffuse Intrinsic Pontine Glioma (DIPG)
Separately, research comparing children with different brainstem tumor locations found that tumors centered in the pons were associated with significantly worse behavioral and emotional scores than tumors in other parts of the brainstem. Children with pontine tumors scored higher on measures of withdrawal, anxiety, depression, attention deficits, and aggressive behavior.14PubMed Central. Brainstem tumors may increase the impairment of behavioral emotional cognition in children The effect is not subtle: a pontine tumor location carried roughly four and a half times the odds of more severe neuropsychiatric symptoms compared to tumors elsewhere in the brainstem.15PubMed Central. Brainstem tumors may increase the impairment of behavioral emotional cognition in children
This matters for families because a child who becomes suddenly irritable, refuses to go to school, or has unexplained emotional outbursts might be evaluated for anxiety, depression, or behavioral disorders long before anyone orders brain imaging. The behavioral presentation can delay diagnosis, especially when the early neurological signs are mild enough to miss on a routine exam.
How Symptoms Respond to Radiation
Radiation therapy is the only treatment that reliably produces temporary symptom improvement in DIPG. Although it does not cure the disease, it can offer meaningful relief. A study tracking neurological symptoms during radiation found that most children began improving at relatively low doses: cranial nerve symptoms started improving at a median dose of about 16 Gy, long tract signs around 20 Gy, and cerebellar signs around 22 Gy. By the end of the full radiation course, more than 80 percent of patients with a given symptom at baseline showed improvement in that symptom.16PubMed Central. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma
Steroid medication (dexamethasone) is usually given alongside radiation to reduce brain swelling, and the fact that symptoms improved even as steroid doses were being tapered suggests the radiation itself was responsible. The median daily steroid dose dropped from 8 mg at the start of radiation to 0.5 mg by the end, and about 40 percent of children were able to stop steroids entirely by the time radiation was complete.17PubMed Central. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma
The improvement is real but temporary. After a period that typically lasts a few months, the tumor resumes its growth and symptoms return, often worse than before. Families should understand that the window of improvement following radiation is a window, not a turning point. It can be a valuable period for quality of life, but planning for symptom progression remains important.
How Symptoms Evolve as the Disease Progresses
As DIPG advances, the spectrum of symptoms broadens and intensifies. A survey of palliative and end-of-life symptoms in children with DIPG found that the most frequently encountered problems were headache, gait disturbance, vomiting, difficulty swallowing, sensory loss, seizures, and constipation.18PubMed. Palliative and end-of-life symptoms management for children with diffuse intrinsic pontine glioma In end-stage disease, more than 78 percent of children experienced problems with mobility, swallowing, communication, consciousness, and breathing.19PubMed Central. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey
Swallowing dysfunction (dysphagia) deserves special mention because it creates cascading problems. A child who cannot swallow safely is at risk for aspiration pneumonia, cannot take medications by mouth, and loses the social and emotional comfort of eating with family. Many children eventually require a feeding tube. Communication loss is equally devastating: as facial weakness, tongue weakness, and cerebellar dysfunction worsen, speech becomes unintelligible, and children who were once verbal may lose the ability to communicate their needs. Breathing problems in late-stage disease reflect the tumor’s encroachment on brainstem centers that regulate respiration. Irregular breathing patterns, periods of apnea, and the need for supplemental oxygen are common in the final weeks.
When DIPG Occurs in Adults
DIPG is overwhelmingly a pediatric disease, and the vast majority of research focuses on children. When pontine gliomas do occur in adults, the symptoms are broadly similar but tend to develop more slowly. Adult cases have been reported to progress less rapidly than pediatric ones, which may give adults a somewhat longer window between first symptoms and diagnosis.20Neurology India. Diffuse intrinsic pontine gliomas in adults: A retrospective study – Section: Discussion However, the overall prognosis remains poor regardless of age.
Molecularly, the same H3 K27M mutation that drives most pediatric DIPGs also appears in adult diffuse midline gliomas, though in adults these tumors are more frequently located in the thalamus rather than the brainstem.21Indian Journal of Neurosurgery. H3 K27M-Altered Diffuse Midline Gliomas: A Review A thalamic location produces a different symptom profile, with more prominent headaches, visual field loss, and cognitive changes rather than the cranial nerve palsies and ataxia that characterize pontine tumors. Adults who do develop a pontine tumor, however, experience the same cranial nerve and cerebellar symptoms as children.
Conditions That Can Look Like DIPG
DIPG is typically diagnosed by its appearance on MRI rather than by biopsy, which means the radiographic picture matters enormously. The classic imaging finding is a mass that is centered in and expands the pons, takes up more than half of the pons’s cross-section, and has no clear borders separating it from normal tissue. When the MRI picture is this textbook, the diagnosis is fairly straightforward.
The trouble comes when the imaging features are atypical. Inflammatory conditions, infections, and demyelinating diseases can all produce lesions in the pons that mimic DIPG on a scan. One case report described a child whose brainstem mass turned out to be an overlap of autoimmune conditions rather than a tumor, a distinction that only became clear after a biopsy.22PubMed Central. Neuromyelitis optica spectrum disorder and autoimmune glial fibrillary acidic protein astrocytopathy overlap syndrome mimicking a pontine mass: The utility of brainstem biopsy Because the treatment for DIPG (radiation) and the treatment for an autoimmune brainstem inflammation (immunosuppression) are completely different, getting the diagnosis right is critical. When imaging features are not entirely classic, or when the clinical course does not follow the expected trajectory, a biopsy may be warranted even though it was historically avoided for pontine tumors.
The Link Between Molecular Subtype and Outcome
Not all DIPGs behave identically, and molecular testing has revealed meaningful subgroups. The H3 K27M mutation in the histone H3.3 gene is present in roughly 71 percent of DIPGs tested in one major study. Children whose tumors carried this mutation had universally short survival, while all long-term survivors in the study had tumors without the mutation.23PubMed Central. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas A separate multi-center analysis confirmed that H3 K27M-mutant and wild-type tumors presented with similarly short symptom histories of about two months on average, so the mutation does not change how symptoms appear initially. It does, however, change how quickly the disease progresses after treatment.24Neuro-Oncology. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
For families, this means that two children who present with identical symptoms and similar-looking MRIs can have meaningfully different trajectories depending on the tumor’s molecular makeup. Biopsy and molecular profiling, which have become increasingly standard as clinical trials require specific mutations for enrollment, can provide prognostic information that the clinical picture alone cannot.
What Families and Caregivers Should Know About Quality of Life
The accumulation of symptoms in DIPG takes a heavy toll not just on the child but on the entire family. Research on parents of children with brain tumors that have a minimal chance for cure found that the child’s cognitive problems and anxiety around medical procedures were significantly associated with poorer parental mental health.25PubMed Central. Children With Minimal Chance for Cure: Parent Proxy of the Child’s Health-Related Quality of Life and the Effect on Parental Physical and Mental Health During Treatment This is not surprising, but it underscores an important point: symptom management in DIPG is not just about the child. Keeping the child as comfortable and functional as possible has measurable effects on the wellbeing of parents and siblings.
Palliative care teams that specialize in pediatric brain tumors can help manage symptoms like pain, nausea, and sleep disruption while also providing emotional and logistical support to families navigating the progression of the disease. Early integration of palliative care, rather than waiting for end-of-life, allows for better symptom control during the window after radiation when the child is often feeling relatively well, and prepares families for the changes ahead. The breadth of symptoms that DIPG produces, from double vision at diagnosis to breathing difficulties in the final stage, means that symptom management is not a single conversation but an ongoing, evolving process.